Catalog Number:
CPTC-EGFR-6
RRID:
AB_2722050
Target Antigen:
Epidermal Growth Factor Receptor Peptide 1
Isotype:
IgG1
Species:
Mouse Monoclonal Antibody
Last Updated:
07/19/2024
Antigen Recognition(s):
Peptide, Recombinant Full-length, Endogenous
Thematic Panel(s):
Ras Pathway
Result: Positive
Imaging mass cytometry on normal lung tissue core using CPTC-EGFR-6 metal-labeled antibody. Data shows an overlay of the target protein signal (red) and DNA (blue). Dilution: 1:100 of 0.5mg/mL stock. Signal was also obtained in other normal tissues (colon, lung, appendix, and kidneys) and cancer tissue (colon).
Result: Negative
Flow cytometric analysis of epidermal growth factor receptor (EGFR) cell surface expression using CPTC-EGFR-6 antibody. H-226 cells were blocked, stained with CPTC-EGFR-6 (solid green) or concentration-matched mouse IgG1 isotype control (dashed green) antibodies and then fixed. HL-60 cells were blocked, stained with CPTC-EGFR-6 (solid blue) or concentration-matched mouse IgG1 isotype control (dashed blue) antibodies, and then fixed. A BV421 conjugated goat anti-mouse IgG was used as a secondary antibody. All data were analyzed using FlowJo.
Result: Negative
Results provided by the Human Protein Atlas (www.proteinatlas.org).
Result: Positive
Tissue Micro-Array (TMA) core of colon cancer showing cytoplasmic and membranous staining using Antibody CPTC-EGFR-6. Titer: 1:5000
Result: Positive
Immuno-MRM chromatogram of CPTC-EGFR-6 antibody with CPTC-EGFR peptide 1 (NCI ID#00112) as target
Result: Negative
Immunofluorescence staining of MCF10a cells stably transfected with KRAS (MCF10a-KRAS) using CPTC- EGFR-6 antibody. EGFR protein expression was not detected.
Result: Negative
Immunofluorescence staining using CPTC-EGFR-6 as primary antibody against HL-60 and NCI H226 cells. EGFR protein expression shows no localization in either cell lines.
Result: Negative
Results provided by the Human Protein Atlas (www.proteinatlas.org).
Result: Negative
This antibody is not suitable for use in a Reverse Phase Protein Array format as described in SOP M-105.
Result: Positive
Western blot using CPTC-EGFR-6 of recombinant EGFR in over-expressed lysate. The antibody is able to detect the target protein. Expected MW is 134 KDa.
Result: Positive
SW using CPTC-EGFR-6 as primary antibody against the over-expressed lysate of EGFR. The antibody is able to recognize the recombinant protein.
Result: Negative
Western blot using CPTC-EGFR-6 as primary antibody against the whole cell lysates of A498, ACHN, H226, H322M, CCRF-CEM and HL-60. The antibody is not able to detect the target protein in any of the tested cell lines.
Result: Positive
Single cell western blot using CPTC-EGFR-6 as a primary antibody against HL-60 and NCI H226 cell lysates. Relative expression of total EGFR in HL-60 and NCI H226 cells (A). Percentage of cells expressing EGFR (B). Average expression of EGFR protein per cell (C). All data is normalized to β-tubulin expression.
Result: Positive
SW using CPTC-EGFR-6 as primary antibody against the whole lysates of A498, ACHN, H226, H322M, CCRF-CEM and HL-60. The antibody is able to recognize the endogenous protein in A498, ACHN, H226 and H322M.
NCI Identification Number:
00112
Antigen Name:
Epidermal Growth Factor Receptor Peptide 1
CPTC Name:
CPTC-EGFR Peptide 1
Aliases:
Epidermal Growth Factor Receptor; Receptor Tyrosine-Protein Kinase ErbB-1; Erb-B2 Receptor Tyrosine Kinase 1; Proto-Oncogene C-ErbB-1; EC 2.7.10.1; ERBB; HER1; ERBB1; Epidermal Growth Factor Receptor (Avian Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog); Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog (Avian); Avian Erythroblastic Leukemia Viral (V-Erb-B) Oncogene Homolog; Cell Proliferation-Inducing Protein 61; Cell Growth Inhibiting Protein 40; EC 2.7.10; NISBD2; PIG61; MENA
Function:
The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. Multiple alternatively spliced transcript variants that encode different protein isoforms have been found for this gene.
EGFR (Epidermal Growth Factor Receptor) is a Protein Coding gene. Diseases associated with EGFR include lung cancer and inflammatory skin and bowel disease, neonatal, 2. Among its related pathways are PI3K-Akt signaling pathway and PI-3K cascade. GO annotations related to this gene include identical protein binding and chromatin binding. An important paralog of this gene is TNK1.
Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. Known ligands include EGF, TGFA/TGF-alpha, amphiregulin, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF. Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules. May also activate the NF-kappa-B signaling cascade. Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling. Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin. Isoform 2 may act as an antagonist of EGF action.
The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase of the ErbB family. Four members of the ErbB family have been identified; EGFR (ErbB1, HER1), ErbB2 (HER2), ErbB3 (HER3) and ErbB4 (HER4). EGFR signaling is initiated by ligand binding to the extracellular ligand binding domain. This initiates receptor homo-/hetero-dimerization and autophosphorylation by the intracellular kinase domain, resulting in receptor activation. Following activation, phosphorylation of cytoplasmic substrates occurs and a signaling cascade is initiated that drives many cellular responses, including changes in gene expression, cytoskeletal rearrangement, anti-apoptosis and increased cell proliferation.
Chromosomal Localization:
7p12
Accession Number:
NP_005219.2
UniProt Accession Number:
P00533
DNA Source:
N/A
Immunogen:
Synthetic Peptide
Vector Name:
N/A
Extinction Coefficient:
Buffers:
Expressed Sequence:
IPLENLQIIR
Native Sequence:
Calculated Isoelectric Point:
0
Molecular Weight:
1100
Last Updated:
10/01/2019
No SOPs available.
Get it for free at Adobe.com